Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Investigating the Pharmacokinetic Properties, Safety and Tolerability of NNC0487-0111 in Participants With Various Degrees of Hepatic Impairment and Participants With Normal Hepatic Function

NCT07587710 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07587710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07587710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Investigating the Pharmacokinetic Properties, Safety and Tolerability of NNC0487-0111 in Participants With Various Degrees of Hepatic Impairment and Participants With Normal Hepatic Function
Lead sponsor
Novo Nordisk A/S
Phase
Phase 1
Overall status
Not yet recruiting
Start date
May 13, 2026
Completion date
December 1, 2027
Enrollment
35 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight